FDA-approved Medications

The US Food and Drug Administration (FDA) approves product labeling for prescription drugs for the purpose of ensuring patient care and safety and educating providers. It is important that PCCs:

• Recognize the FDA-approved indications for the use of stimulant and related medications in pediatric patients.
• Follow AAP-approved treatment guidelines for the management of ADHD in pediatric patients.
• Are familiar with benefits and adverse reactions and risks of using stimulant and related medications in pediatric patients and help parents/caregivers/patients (as age appropriate) understand them.

Shared Decision Making tools to help caregivers understand the pros and cons of psychosocial treatments as well as the various FDA-approved ADHD medication options are available at: https://www.cincinnatichildrens.org/service/j/anderson-center/evidence-based-care/decision-aids.